AssetMark Inc’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $537K | Buy |
18,667
+603
| +3% | +$17.3K | ﹤0.01% | 1034 |
|
2025
Q1 | $606K | Sell |
18,064
-97
| -0.5% | -$3.25K | ﹤0.01% | 950 |
|
2024
Q4 | $929K | Buy |
18,161
+1,014
| +6% | +$51.8K | ﹤0.01% | 865 |
|
2024
Q3 | $876K | Buy |
17,147
+2,030
| +13% | +$104K | ﹤0.01% | 807 |
|
2024
Q2 | $677K | Buy |
15,117
+4,331
| +40% | +$194K | ﹤0.01% | 831 |
|
2024
Q1 | $505K | Buy |
+10,786
| New | +$505K | ﹤0.01% | 829 |
|